Neurothera Labs Inc. (TSXV:NTLX)
Canada · Delayed Price · Currency is CAD 0.2000
+0.0300 (17.65%)
At close: Jan 30, 2026
Neurothera Labs Company Description
Neurothera Labs Inc. operates a clinical-stage pharmaceutical company.
The company engages in the drug development programs based on THC and/or non-psychoactive CBD: SCI-110 for the treatment of Tourette syndrome, for the treatment of Alzheimer's disease and agitation; and SCI- 210 for the treatment of ASD and status epilepticus.
Neurothera Labs Inc. was formerly known as Miza III Ventures Inc. The company is based in Vancouver, Canada.
As of February 23, 2023, Neurothera Labs Inc. operates as a subsidiary of SciSparc Ltd.
Neurothera Labs Inc.
| Country | Canada |
| Industry | Shell Companies |
| Sector | Financials |
Contact Details
| Website | neurothera.com |
Stock Details
| Ticker Symbol | NTLX |
| Exchange | TSX Venture Exchange |
| Reporting Currency | CAD |
| SIC Code | 2834 |